1 | ACAD | ACADIA Pharmaceuticals Inc. | 4.48% |
2 | NBIX | Neurocrine Biosciences, Inc. | 4.45% |
3 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.09% |
4 | ILMN | Illumina, Inc. | 3.95% |
5 | MRNA | Moderna, Inc. | 3.79% |
6 | EXEL | Exelixis, Inc. | 3.78% |
7 | EXAS | Exact Sciences Corporation | 3.77% |
8 | INCY | Incyte Corporation | 3.66% |
9 | MTD | Mettler-Toledo International Inc. | 3.54% |
10 | BNTX | BioNTech SE | 3.51% |
11 | BIIB | Biogen Inc. | 3.50% |
12 | GMAB | Genmab A/S | 3.47% |
13 | ALKS | Alkermes plc | 3.36% |
14 | ONC | BeOne Medicines Ltd. | 3.36% |
15 | GILD | Gilead Sciences, Inc. | 3.31% |
16 | NTRA | Natera, Inc. | 3.31% |
17 | BRKR | Bruker Corporation | 3.29% |
18 | WAT | Waters Corporation | 3.25% |
19 | UTHR | United Therapeutics Corporation | 3.24% |
20 | RGEN | Repligen Corporation | 3.20% |
21 | BMRN | BioMarin Pharmaceutical Inc. | 3.18% |
22 | AMGN | Amgen Inc. | 3.14% |
23 | CORT | Corcept Therapeutics Incorporated | 3.13% |
24 | REGN | Regeneron Pharmaceuticals, Inc. | 3.02% |
25 | VRTX | Vertex Pharmaceuticals Incorporated | 2.99% |
View FBT holdings |